Global collaboration to combat chronic lung infection
Researchers develop drug target to tackle multi-drug resistant lung bacterium.
Researchers develop drug target to tackle multi-drug resistant lung bacterium.
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for...
Griffith University will use a $2.95 million NHMRC grant to take a unique focus on targeting sugar interactions to prevent...
Advanced bionic limb development, malaria drug mechanisms, skin immune response to mosquito-borne infections among new Ideas Grants.
Vaginal microbes are at the centre of a novel discovery that aims to investigate if these bacteria trap HIV or act as a courier service to deliver the virus to the host within the human body.
Griffith University researchers are making inroads in ovarian cancer research looking at early detection signs and how the disease spreads through the body.
Griffith University researchers will lead 17 new Discovery Projects across a broad field of knowledge after being awarded over $7.735 million from the Australian Research Council.
Griffith named in nation-wide research rankings.
Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.
Some of Griffith University’s most outstanding research students have been acknowledged at the Institute for Glycomics Student Scholarships Awards evening....